ReviewClinical drug investigation2009

Implications of the European Organisation for Research And Treatment Of Cancer (EORTC) guidelines on the use of granulocyte colony-stimulating factor (G-CSF) for lymphoma care.

Ruth Pettengell et al.PubMed ↗Publisher ↗

No numbers read from the abstract.